Breaking News, Promotions & Moves

BioConnection Appoints Chief Commercial Officer

Richard Sewalt offers more than 20 years of experience in the biopharmaceutical industry.

Author Image

By: Charlie Sternberg

Associate Editor

BioConnection, a Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, has appointed Richard Sewalt as its new Chief Commercial Officer (CCO). With his extensive background and proven expertise, Sewalt will be a key driver of BioConnection’s success and growth.   Sewalt brings more than 20 years of experience in the biopharmaceutical industry and global commercialization in a business-to-business environment. During his career, he has served in severa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters